Human VEGFR2/KDR Quantikine ELISA Kit
Catalog # DVR200 | R&D Systems, Inc. a Bio-Techne Brand
Key Product Details
Assay Length: | 4.5 hours |
Sample Type & Volume Required Per Well: | Cell Culture Supernates (100 uL), Cell Lysates (100 uL), Serum (20 uL), EDTA Plasma (20 uL), Heparin Plasma (20 uL) |
Sensitivity: | 11.4 pg/mL |
Assay Range: | 78.1 - 5,000 pg/mL (Cell Culture Supernates, Cell Lysates, Serum, EDTA Plasma, Heparin Plasma) |
Human VEGFR2/KDR Quantikine ELISA Kit Summary: | The Quantikine Human VEGF R2 Immunoassay is a 4.5 hour solid-phase Immunoassay designed to measure human soluble VEGF R2 in cell culture supernates, cell lysates, serum, and plasma. It contains NS0-expressed recombinant human VEGF R2/Fc Chimera and has been shown to accurately quantitate the recombinant factor. Results obtained using natural human VEGF R2 showed linear curves that were parallel to the standard curves obtained using the Quantikine kit standards. These results indicate that this kit can be used to determine relative mass values for naturally occurring human soluble VEGF R2. |
Customers also Viewed
Customers also Purchased
Citations for Human VEGFR2/KDR Quantikine ELISA Kit (36)
Citations are publications that use Bio-Techne products. Selected citations for Human VEGFR2/KDR Quantikine ELISA Kit include:
-
Species: Human
Sample Types: Serum
V Rosiek et al. (2023-03-10), Association between Biomarkers (VEGF-R2, VEGF-R3, VCAM-1) and Treatment Duration in Patients with Neuroendocrine Tumors Receiving Therapy with First-Generation Somatostatin Analogues Biomedicines, 2023-011(3).
PMID: 36979820 -
Species: Human
Sample Types: Plasma
L Fornaro et al. (2022-07-15), Early increase of plasma soluble VEGFR-2 is associated with clinical benefit from second-line treatment of paclitaxel and ramucirumab in advanced gastric cancer American journal of cancer research, 2022-012(7):3347-3356.
PMID: 35968330 -
Species: Human
Sample Types: Plasma
C Jiguet-Jig et al. (2022-01-03), Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: an AVAglio ancillary study Acta neuropathologica communications, 2022-010(1):1.
PMID: 34980260 -
Species: Human
Sample Types: Serum
L Zilberman et al. (2021-05-06), Residual alterations of cardiac and endothelial function in patients who recovered from Takotsubo cardiomyopathy Clinical cardiology, 2021-00(0).
PMID: 33955558 -
Species: Human
Sample Types: Cell Culture Supernates
D Dong et al. (2020-11-20), Hyperoxia sensitizes hypoxic HeLa cells to ionizing radiation by downregulating HIF?1&alpha and VEGF expression Mol Med Rep, 2020-123(1).
PMID: 33215223 -
Species: Human
Sample Types: Serum
A Waszczykow et al. (2020-11-18), Matrix Metalloproteinases MMP-2 and MMP-9, Their Inhibitors TIMP-1 and TIMP-2, Vascular Endothelial Growth Factor and sVEGFR-2 as Predictive Markers of Ischemic Retinopathy in Patients with Systemic Sclerosis-Case Series Report Int J Mol Sci, 2020-121(22).
PMID: 33218057 -
Species: Human
Sample Types: Plasma
RC Barbara et al. (2020-06-02), Divergent Impact of Breast Cancer Laterality on Clinicopathological, Angiogenic, and Hemostatic Profiles: A Potential Role of Tumor Localization in Future Outcomes J Clin Med, 2020-09(6).
PMID: 32498398 -
Species: Human
Sample Types: Plasma
C Fountzilas et al. (2020-02-10), A multicentre phase 1b/2 study of tivozanib in patients with advanced inoperable hepatocellular carcinoma Br. J. Cancer, 2020-00(0).
PMID: 32037403 -
Species: Human
Sample Types: Serum
H Takaya et al. (2019-10-21), VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma BMC Gastroenterol, 2019-119(1):167.
PMID: 31638892 -
Species: Human
Sample Types: Plasma
E Zarychta et al. (2019-02-26), Anti-angiogenic efficacy in invasive breast carcinoma patients depends on clinicopathological determinants Adv Med Sci, 2019-064(2):216-223.
PMID: 30818220 -
Species: Human
Sample Types: Serum
J Sánchez Ra et al. (2017-07-26), Characteristics of the specific humoral response in patients with advanced solid tumors after active immunotherapy with a VEGF vaccine, at different antigen doses and using two distinct adjuvants BMC Immunol., 2017-018(1):39.
PMID: 28747172 -
Species: Human
Sample Types: Cell Culture Supernates
Sushil Panta (2016-12-18), Low grade inflammation inhibits VEGF induced HUVECs migration in p53 dependent manner Biochem. Biophys. Res. Commun, 2016-10(0).
PMID: 27998768 -
Species: Human
Sample Types: Plasma
Günay Kalender (2016-12-14), Kinetics of circulating endothelial progenitor cells in patients undergoing carotid artery surgery Ther Clin Risk Manag, 2016-112(0):1841-1847.
PMID: 28008262 -
Species: Human
Sample Types: Plasma
Salazar R et al. (2015-02-26), A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features. BMC Cancer, 2015-015(0):60.
PMID: 25886378 -
Species: Human
Sample Types: Serum
Sallinen H et al. (2014-09-23), Serum angiopoietin-2 and soluble VEGFR-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer. BMC Cancer, 2014-014(0):696.
PMID: 25245329 -
Species: Human
Sample Types: Plasma
Necchi A et al. (2013-11-14), Analysis of plasma cytokines and angiogenic factors in patients with pretreated urothelial cancer receiving Pazopanib: the role of circulating interleukin-8 to enhance the prognostic accuracy. Br J Cancer, 2013-1110(1):26-33.
PMID: 24231947 -
Species: Human
Sample Types: Plasma
Briasoulis et al. (2013-05-29), Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study. BMC Cancer, 2013-013(1):263.
PMID: 23718900 -
Species: Human
Sample Types: Cell Lysates, Vitreous Humor
Abu El-Asrar et al. (2013-03-10), Angiogenic and vasculogenic factors in the vitreous from patients with proliferative diabetic retinopathy. J Diabetes Res, 2013-00(0):539658.
PMID: 23671874 -
Species: Human
Sample Types: Plasma
Jurgensmeier J et al. (2013-02-28), Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy. Br J Cancer, 2013-0108(6):1316-23.
PMID: 23449351 -
Species: Human
Sample Types: Plasma
Somlo G et al. (2013-02-12), Dasatinib plus capecitabine for advanced breast cancer: safety and efficacy in phase I study CA180004. Clin Cancer Res, 2013-019(7):1884-93.
PMID: 23403636 -
Species: Human
Sample Types: Plasma
Widemann B et al. (2012-09-07), A phase I trial and pharmacokinetic study of sorafenib in children with refractory solid tumors or leukemias: a Children's Oncology Group Phase I Consortium report. Clin Cancer Res, 2012-018(21):6011-22.
PMID: 22962440 -
Species: Human
Sample Types: Serum
(2012-07-17), Cytokine and angiogenic factors associated with efficacy and toxicity of pazopanib in advanced soft-tissue sarcoma: an EORTC-STBSG study. Br. J. Cancer, 2012-0107(4):639-45.
PMID: 22805326 -
Species: Human
Sample Types: Serum
Landt S et al. (2011-08-01), Prognostic significance of angiogenic factors in uterine cervical cancer. Anticancer Res., 2011-031(8):2589-95.
PMID: 21778309 -
Species: Human
Sample Types: Plasma
Harmon CS et al. (2011-07-25), Mechanism-related circulating proteins as biomarkers for clinical outcome in patients with unresectable hepatocellular carcinoma receiving sunitinib. J Transl Med, 2011-09(0):120.
PMID: 21787417 -
Species: Human
Sample Types: Plasma
Dubois SG et al. (2011-06-20), Phase I and pharmacokinetic study of sunitinib in pediatric patients with refractory solid tumors: a children's oncology group study. Clin. Cancer Res., 2011-017(15):5113-22.
PMID: 21690570 -
Species: Human
Sample Types: Plasma
de Groot JF et al. (2011-06-01), Myeloid Biomarkers Associated with Glioblastoma Response to Anti-VEGF Therapy with Aflibercept. Clin. Cancer Res., 2011-017(14):4872-4881.
PMID: 21632852 -
Species: Human
Sample Types: Plasma
Loupakis F et al. (2011-03-15), Pharmacodynamic and pharmacogenetic angiogenesis-related markers of first-line FOLFOXIRI plus bevacizumab schedule in metastatic colorectal cancer. Br. J. Cancer, 2011-0104(8):1262-9.
PMID: 21407216 -
Species: Human
Sample Types: Plasma
Farace F et al. (2011-03-08), Levels of circulating CD45(dim)CD34(+)VEGFR2(+) progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors. Br. J. Cancer, 2011-0104(7):1144-50.
PMID: 21386843 -
Species: Human
Sample Types: Serum
Konings IR et al. (2010-09-07), Phase I and pharmacological study of the broad-spectrum tyrosine kinase inhibitor JNJ-26483327 in patients with advanced solid tumours. Br. J. Cancer, 2010-0103(7):987-92.
PMID: 20823884 -
Species: Human
Sample Types: Plasma
Zhu AX et al. (2009-05-26), Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study. J. Clin. Oncol., 2009-027(18):3027-35.
PMID: 19470923 -
Species: Human
Sample Types: Serum
Bourlev V et al. (2009-03-25), Signs of reduced angiogenic activity after surgical removal of deeply infiltrating endometriosis. Fertil. Steril., 2009-094(1):52-7.
PMID: 19324337 -
Species: Human
Sample Types: Plasma
Sallinen H et al. (2008-12-02), Antiangiogenic gene therapy with soluble VEGFR-1, -2, and -3 reduces the growth of solid human ovarian carcinoma in mice. Mol. Ther., 2008-117(2):278-84.
PMID: 19050699 -
Species: Human
Sample Types: Plasma
Burstein HJ et al. (2008-03-17), Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane. J. Clin. Oncol., 2008-026(11):1810-6.
PMID: 18347007 -
Species: Human
Sample Types: Plasma
Saltz LB et al. (2007-10-20), Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapy. J. Clin. Oncol., 2007-125(30):4793-9.
PMID: 17947727 -
Species: Human
Sample Types: Plasma
Norden-Zfoni A et al. (2007-05-01), Blood-based biomarkers of SU11248 activity and clinical outcome in patients with metastatic imatinib-resistant gastrointestinal stromal tumor. Clin. Cancer Res., 2007-013(9):2643-50.
PMID: 17473195 -
Species: Human
Sample Types: Serum
Wallner W et al. (2007-01-01), Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. Clin. Sci., 2007-0112(1):51-7.
PMID: 16928195
There are no citations that match your criteria.
Customer Reviews for Human VEGFR2/KDR Quantikine ELISA Kit (2)
Customer Images
-
Sample Tested: HUVEC human umbilical vein endothelial cells,TeloHAECVerified Customer | Posted 08/26/2020
-
Sample Tested: Human cell conditioned mediumVerified Customer | Posted 06/23/2017
There are no reviews that match your criteria.
Product Documents for Human VEGFR2/KDR Quantikine ELISA Kit
⚠ WARNING: This product can expose you to chemicals including N,N-Dimethylforamide, which is known to the State of California to cause cancer. For more information, go to www.P65Warnings.ca.gov.